Company intelligence / Profile preview
Lincbiotech
Santiago de Compostela, Galicia, Spainlincbiotech.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Lincbiotech develops innovative diagnostic and therapeutic tools focused on high-prevalence neurological diseases, especially stroke and Alzheimer’s. Their flagship products include the Minerva clinical decision support system to aid clinicians managing stroke patients, next-generation monoclonal antibodies targeting aberrant Tau species relevant to Alzheimer's pathology, and a novel ELISA kit enabling early detection of misfolded proteins in cerebrospinal fluid. The company aims to improve prognosis through earlier diagnosis and enhanced patient management.
- Therapeutic areas
- Neurology
- Modalities
- Monoclonal antibodies (mAbs)ELISA diagnostic kitsClinical decision support systems (CDSS)
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Lincbiotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lincbiotech.